Harness for working animal
Reexamination Certificate
2007-11-20
2007-11-20
Carlson, Karen Cochrane (Department: 1656)
Harness for working animal
C530S350000
Reexamination Certificate
active
10981737
ABSTRACT:
The invention relates to the use of osteopontin, or of an agonist of osteopontin activity, for treatment or prevention of a neurologic diseases.
REFERENCES:
patent: WO00/37502 (2000-08-01), None
patent: WO00/63241 (2000-10-01), None
patent: WO00/64460 (2000-11-01), None
patent: WO01/24831 (2001-04-01), None
Altschul S F et al, (1990) “Basic Local Alignment Search Tool” J Mol Biol. 215: 403-410.
Barres, B.A., and Raff, M.C. (Dec. 13, 1999). “Axonal Control Of Oligodendrocyte Development”. Journal of Cell Biology. 147(6): 1123-1128.
Barres, B.A., et al. (1993). “Multiple Extracellular Signals Are Required For Long-Term Oligodendrocyte Survival”. Development. 118(1): 283-295.
Bjartmar, C., et al (1999). “Axonal Pathology In Myelin Disorders”. Journal of Neurocytology. 28: 383-395.
Breighton, B and Hayden, MR: S, (Feb. 21, 1981). “Huntington's Chorea” Afr Med J.; 59(8): 250.
Dal Canto, M.C., et al (1995). “Two Models Of Multiple Sclerosis: Experimental Allergic Encephalomyelitis (EAE) and Theiler's Murine Encephalomyelitis Virus (TMEV) Infection. A Pathological And Immunological Comparison”. Microsc. Res. Tech. 32(3): 215-29.
Derynk R. et al., (1980). “Isolation And Structure Of A Human Fibroblast Interferon Gene” Nature 285: 542-547.
Devereux J et al, (1984). “A Comprehensive Set Of Sequence Analysis Programs For The VAX” Nucleic Acids Res, 12(1): 387-395.
Dubois-Dalcq, M., et al. (1999). “The Neurobiology Of X-Linked Adrenoleukodystrophy, A Demyelinating Peroxisomal Disorder”. Trends in Neurosciences 22(1): 4-12.
Dubois-Dalcq, M., and Murray, K. (2000). “Why Are Growth Factors Important In Oligodendrocyte Physiology?” Pathol Biol (Paris) 48(1): 80-86,.
Fernández, P.A., et al. (2000). “Evidence That Axon-Derived Neuregulin Promotes Oligodendrocyte Survival In The Developing Rat Optic Nerve”. Neuron 28(1): 81-90.
Franklin, R.J., and Hinks, G.L. (1999). “Understanding CNS Remyelination: Clues From Developmental And Regeneration Biology”. Journal of Neuroscience Research 58(2): 207-213.
Grantham, (1974). “Amino Acid Difference Formula to Help Explain Protein Evolution”, Science. 185: 862-864.
Grinspan, J.B., et al. (1996). “Re-Entry Into The Cell Cycle Is Required For Bfgf-Induced Oligodendroglial Dedifferentiation And Survival”. Journal of Neuroscience Research. 46(4): 456-464.
Grinspan, J.B., et al (1993). “Trophic Effects Of Basic Fibroblast Growth Factor (bFGF) On Differentiated Oligodendroglia: A Mechanism For Regeneration Of The Oligodendroglial Lineage”. Journal of Neuroscience Research. 36(6): 672-680.
Hajihosseini, M., et al (Dec. 15, 1996). “Origin Of Oligodendrocytes Within The Human Spinal Cord”. Journal of Neuroscience. 16(24): 7981-7994.
Hartung, H.P., et al (1998). “Guillain-Barre Syndrome, CIDP And Other Chronic Immune-Mediated Neuropathies”. Current Opinion in Neurology. 11: 497-513.
Hiremath, M.M., et al (1998). “Microglial/macrophage Accumulation During Cuprizone-Induced Demyelination in C57BL/6 Mice”. Journal of Neuroimmunology. 92(1-2): 38-49.
Ichikawa H, et al (2000). “Osteopontin-Immunoreative Primary Sensory Neurons In The Rat Spinal And Trigeminal Nervous System”, Brain Research. 863(1-2):276-281.
Jung, M., et al (1995). “Lines Of Murine Oligodendroglial Precursor Cells Immortalized By An Activated Neu Tyrosine Kinase Show Distinct Degrees Of Interaction With Axons In Vitro And In Vivo”. European Journal of Neuroscience. 7(6): 1245-1265.
Kiefer et al. (Apr. 25, 1989). “The cDNA And Derived Amino Acid Sequence For Human Osteopontin”. Nucleic Acids Res. 17(8):3306.
Kon S, et al (2000). “Antibodies To Different Peptides In Osteopontin Reveal Complexities In The Various Secreted Forms”. Journal of Cellular Biochemistry. 77(3): 487-498.
Kon S, et al (2002). “Mapping Of Functional Epitopes Of Osteopontin By Monoclonal Antibodies Raised Against Defined Internal Sequences”. Journal of Cellular Biochemistry. 84(2): 420-432.
Kunicki, T.J., et al (1997). “Molecular Determinants of arg-gly-asp Ligand Specificity for b3 Integrins”. Journal of Biological Chemistry. 272(7): 4103-4107.
Lee, et al, (Aug. 20, 1999). “Transient Upregulation Of Osteopontin mRNA In Hippocampus And Striatum Following Global Forebrain Ischemia In Rats”. Neuroscience Letters 271(2):81-84.
Lipton, S. A., and Rosenberg, P. A. (Mar. 3, 1994). “Excitatory Amino Acids As A Final Common Pathway For Neurologic Disorders”. New England Journal of Medicine. 330: 613-22.
Loius, J.C., et al (1992). “CG-4 A New Bipontial Glial Cell Line From Rat Brain, Is Capable Of Differentiating In Vitro Into Either Mature Oligodendrocytes Or Type-2 Astrocytes”. Journal of Neuroscience Research 31: 193-204.
Lubetzki, C., et al, (1993). “Even In Culture, Oligodendrocytes Myelinate Solely Axons”. Proceedings of the National Academy of Sciences of the USA. 90:6820-6824.
Marchionni, M.A., et al, (1999). “Neuregulin In Neuron/Glial Interactions In The Central Nervous System. GGF2 Diminishes Autoimmune Demyelination, Promotes Oligodendrocyte Progenitor Expansion, And Enhances Remyelination”. Advances in Experimental and Medical Biology. 468: 283-295.
Mark et al. (Sep. 1984). “Site-Specific Mutagenesis Of The Human Fibroblast Interferon Gene”. Proc. Natl. Acad. Sci. USA., 81: 5662-5666.
Matthieu, J.M., et al, (1992). “Myelin Gene Expression During Demyelination And Remyelination In Aggregating Brain Cell Cultures”. Journal of Neuroimmunology. 40(2-3): 231-234.
McDonald, J. W., et al, (1998). “Oligodendrocytes From Forebrain Are Highly Vulnerable To AMPA/kainate Receptor-Mediated Excitotoxicity”. Nature Medicine. 4(3): 291-297.
Morell, P., et al, (1998). “Gene Expression In Brain During Cuprizone-Induced Demyelination And Remyelination”. Molecular and Cellular Neurosciences. 12(4/5): 220-227.
Nait-Oumesmar, et al, (1999). “Progenitor Cells Of The Adult Mouse Subventricular Zone Proliferate, Migrate And Differentiate Into Oligodendrocytes After Demyelination”. European Journal of Neuroscience. 11(12): 4357-4366.
Ng, W.P., et al, (1996). “Human Central Nervous System Myelin Inhibits Neurite Outgrowth”. Brain Research. 720(1-2): 17-24.
Noseworthy, J.H. (1999). “Progress In Determining The Causes And Treatment Of Multiple Sclerosis”. Nature. 399: A40-A47.
Oldberg et al., (Dec. 1986) “Cloning And Sequence Analysis Of Rat Bone Sialoprotein (Osteopontin) cDNA Reveals An Arg-Gly-Asp Cell-Binding Sequence”. Proc Natl Acad Sci USA. 83(23):8819-8823.
Pantoni, L., et al, (1996). “Cerebral White Matter Is Highly Vulnerable To Ischemia”. Stroke. 27(9): 1641-1646.
Pearson W R, (1990). “Rapid And Sensitive Sequence Comparison with FASTP and FASTA”. Methods in Enzymology. 183, 63-99.
Pearson W R and Lipman D J, (Apr. 1988). “Improved Tools For Biological Sequence Comparison”. Proc Nat Acad Sci USA. 85: 2444-2448.
Petry, K.G., et al, (2000). “Experimental Allergic Encephalomyelitis Animal Models For Analyzing Features Of Multiple Sclerosis”. Pathologie Biologie. (Paris) 48(1): 47-53.
Pöhlau, D., et al, (1998). “Promoting Remyelination As A Future Therapeutic Principle In Multiple Sclerosis”. Nervenarzt, 69, 841-850.
Prineas, J.W., et al, (1993). “Multiple Sclerosis: Remyelination Of Nascent Lesions”. Annals of Neurology. 33(2): 137-151.
Rodriguez-Peña, A. (1999) “Oligodendrocyte Development And Thyroid Hormone”. Journal of Neurobiology. 40(4): 497-512.
Rogister, B., et al, (1999). “From Neural Stem Cells To Myelinating Oligodendrocytes”. Molecular and Cellular Neurosciences. 14(4-5): 287-300.
Sahrbacher, U.C., et al,
Bernasconi Lilia
Boschert Ursula
Feger Georg
Papoian Ruben
Selvaraju Raghuram
Browdy & Neimark PLLC
Carlson Karen Cochrane
Laboratoires Serono SA
LandOfFree
Use of osteopontin for the treatment and/or prevention of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of osteopontin for the treatment and/or prevention of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of osteopontin for the treatment and/or prevention of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3877515